In this issue:
Spesolimab in Asian patients with a generalised pustular psoriasis flare
Epidemiological survey of Japanese patients with PsA
Alopecia areata in Japanese patients
Nail psoriasis after 5 years of ixekizumab
Cardiovascular risk factors and disease in women with psoriasis
Safety of conventional and biological systemic therapy in older adults
Modifiable pathways in psoriasis
Cardiometabolic multimorbidity in patients with psoriasis
Guselkumab, tildrakizumab, and risankizumab in a real-world setting
JAK inhibitors for alopecia areata in children
Apremilast in patients with limited skin involvement plaque psoriasis
Please login below to download this issue (PDF)